StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
17
This year
2
Publishing Date
2024 - 02 - 20
1
2024 - 02 - 15
1
2023 - 11 - 29
1
2023 - 11 - 08
1
2023 - 05 - 11
1
2022 - 06 - 24
1
2022 - 06 - 23
1
2022 - 05 - 17
1
2022 - 03 - 23
1
2021 - 12 - 02
1
2021 - 11 - 17
1
2021 - 10 - 18
1
2021 - 09 - 20
1
2021 - 09 - 14
1
2021 - 08 - 23
1
2021 - 07 - 15
1
2021 - 04 - 15
1
Sector
Consumer non-durables
1
Health technology
12
Manufacturing
4
Professional, scientific, and technical services
1
Tags
Acquisition
48
Biotech-beach
14
Business
33
Cancer
19
Ceo
72
Ces
65
Collaboration
17
Commercial
16
Companies
14
Conference
19
Corporation
28
Drug
23
Energy
53
Expansion
14
Fda
53
Financial
24
First
15
Global
29
Group
38
Growth
39
Health
18
International
17
Leo
18
Lithium
15
Liver
17
Management
26
Market
19
Meeting
28
Milestone
23
N/a
1642
Nasdaq
14
Offering
60
Partnership
22
People
17
Pharm-country
19
Pharmaceuticals
16
Phase 1
21
Phase 2
30
Phase 3
14
Platform
18
Pre-clinical
14
Preclinical
15
Program
38
Report
17
Research
55
Results
58
Services
15
Solutions
20
Study
48
Success
324
System
31
Technology
39
Test
45
Therapeutics
28
Therapy
15
Treatment
41
Trial
86
Trials
15
Update
20
Vaccine
17
Entities
Arcturus therapeutics holdings inc.
1
Arrival
2
Biontech se
1
Curevac n.v.
1
Dyadic international, inc.
1
Evaxion biotech a/s - adr
1
Glaxosmithkline plc
1
Ibio, inc.
1
Johnson & johnson
1
Kering
1
Longeveron llc - class a
1
Moderna, inc.
2
Sanofi
1
Soligenix, inc.
3
Thermo fisher scientific inc
1
Vaxxinity, inc.
1
Verve therapeutics inc
1
Zosano pharma corporation
2
Symbols
ARCT
1
ARVL
2
BNTX
1
CVAC
1
DYAI
1
EVAX
1
GLAXF
1
GSK
1
IBIO
1
JNJ
1
LGVN
1
MRNA
2
PPRUF
1
PPRUY
1
SNGX
3
SNY
1
SNYNF
1
TMO
1
VAXX
1
VERV
1
ZSAN
2
Exchanges
Amex
1
Nasdaq
15
Nyse
3
Crawled Date
2024 - 02 - 20
1
2024 - 02 - 15
1
2023 - 11 - 29
1
2023 - 11 - 08
1
2023 - 05 - 11
1
2022 - 06 - 24
1
2022 - 06 - 23
1
2022 - 05 - 17
1
2022 - 03 - 23
1
2021 - 12 - 02
1
2021 - 11 - 17
1
2021 - 10 - 18
1
2021 - 09 - 20
1
2021 - 09 - 14
1
2021 - 08 - 23
1
2021 - 07 - 15
1
2021 - 04 - 15
1
Crawled Time
03:00
1
06:00
1
12:00
2
12:30
2
13:00
3
13:30
1
14:15
1
15:00
2
16:00
1
17:00
1
18:00
1
22:00
1
Source
www.biospace.com
7
www.globenewswire.com
6
www.phreesia.com
1
www.ppdi.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
success
tags :
Vaccine
save search
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
Published:
2024-02-20
(Crawled : 12:30)
- globenewswire.com
EVAX
|
News
|
$4.1
1.49%
1.46%
30K
|
Manufacturing
|
-0.25%
|
O:
9.14%
H:
1.81%
C:
-9.73%
vaccine
ongoing
collaboration
Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published
Published:
2024-02-15
(Crawled : 13:00)
- globenewswire.com
VAXX
|
$0.418
-4.96%
-5.22%
310K
|
|
-37.39%
|
O:
-1.25%
H:
0.0%
C:
-9.96%
candidate
vaccine
cholesterol
preclinical
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Published:
2023-11-29
(Crawled : 13:30)
- globenewswire.com
DYAI
A
|
$1.69
-6.11%
-6.51%
17K
|
Health Technology
|
1.98%
|
O:
-0.85%
H:
5.71%
C:
-2.29%
candidate
vaccine
trial
results
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published:
2023-11-08
(Crawled : 03:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
17.03%
|
O:
1.91%
H:
0.0%
C:
0.0%
VERV
|
$6.74
-5.6%
-5.93%
1.1M
|
Professional, Scientific, and T...
|
-61.82%
|
O:
0.37%
H:
0.64%
C:
-10.76%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
14.21%
|
O:
0.46%
H:
0.46%
C:
-0.23%
MRNA
|
News
S
|
$103.45
-0.33%
-0.33%
2M
|
Health Technology
|
40.9%
|
O:
-0.01%
H:
0.03%
C:
-3.14%
CVAC
|
$2.57
-3.57%
-3.7%
920K
|
Health Technology
|
-51.63%
|
O:
0.91%
H:
1.08%
C:
-1.44%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-15.66%
|
O:
0.13%
H:
0.08%
C:
-2.81%
ARCT
4
|
$27.68
-8.13%
-8.85%
620K
|
Health Technology
|
53.8%
|
O:
-0.36%
H:
0.79%
C:
-0.61%
covid-19
success
report
vaccine
mrna
worldwide
ongoing
research
global
market
Keys to Success in Vaccine Development for Special Populations
Published:
2023-05-11
(Crawled : 16:00)
- ppdi.com
PPRUF
|
News
|
$359.318
37.56%
490
|
Consumer Non-Durables
|
-38.61%
|
O:
1.76%
H:
1.01%
C:
-0.94%
PPRUY
|
News
|
$36.19
-0.11%
360K
|
Manufacturing
|
-39.24%
|
O:
-1.04%
H:
1.12%
C:
1.12%
TMO
|
News
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
|
3.95%
|
O:
-0.26%
H:
0.69%
C:
-0.43%
success
vaccine
Press Release: Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
Published:
2022-06-24
(Crawled : 06:00)
- globenewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-4.79%
|
O:
8.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-9.46%
|
O:
3.49%
H:
0.0%
C:
0.0%
covid-19
report
vaccine
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published:
2022-06-23
(Crawled : 12:00)
- prnewswire.com
SNGX
|
$0.4963
5.15%
-7.27%
4.2M
|
Health Technology
|
-94.74%
|
O:
3.58%
H:
3.23%
C:
-2.9%
vaccine
Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle Patch
Published:
2022-05-17
(Crawled : 18:00)
- biospace.com/
ZSAN
|
$0.5576
7.23%
-5.85%
|
Health Technology
|
-69.7%
|
O:
2.72%
H:
7.32%
C:
6.88%
covid-19
vaccine
Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint
Published:
2022-03-23
(Crawled : 12:30)
- biospace.com/
MRNA
|
News
S
|
$103.45
-0.33%
-0.33%
2M
|
Health Technology
|
-44.41%
|
O:
-1.1%
H:
0.59%
C:
-3.21%
covid-19
children
vaccine
phase 2
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published:
2021-12-02
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4963
5.15%
-7.27%
4.2M
|
Health Technology
|
-45.75%
|
O:
-4.6%
H:
1.22%
C:
-6.0%
vaccine
Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System
Published:
2021-11-17
(Crawled : 15:00)
- biospace.com/
ZSAN
|
$0.5576
7.23%
-5.85%
|
Health Technology
|
-97.44%
|
O:
35.65%
H:
0.68%
C:
-18.77%
covid
vaccine
Mandates, boosters and pediatric vaccines: How to successfully manage the next phase of COVID-19 vaccination
Published:
2021-10-18
(Crawled : 17:00)
- phreesia.com
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-96.25%
|
O:
-1.8%
H:
1.87%
C:
-0.28%
covid
vaccine
covid-19
Defence Therapeutics Successfully Engineered and Tested a Novel Intranasal COVID-19 Vaccine Formulation in Animals
Published:
2021-09-20
(Crawled : 15:00)
- biospace.com/
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
-95.78%
|
O:
-3.65%
H:
0.0%
C:
0.0%
covid
animals
test
vaccine
defense
covid-19
J&J on Pace for Another Vaccine Success, this Time for Ebola
Published:
2021-09-14
(Crawled : 14:15)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-12.88%
|
O:
0.36%
H:
0.08%
C:
-0.96%
vaccine
Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases
Published:
2021-08-23
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.4963
5.15%
-7.27%
4.2M
|
Health Technology
|
-45.58%
|
O:
7.22%
H:
1.4%
C:
0.49%
disease
vaccine
marburg
iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
Published:
2021-07-15
(Crawled : 22:00)
- globenewswire.com
IBIO
|
$1.89
-3.08%
0.0%
270K
|
Health Technology
|
48.85%
|
O:
3.05%
H:
3.7%
C:
-2.22%
covid
leo
vaccine
preclinical
covid-19
pre-clinical
Longeveron Announces Successful Completion of Phase I/II Clinical Study of Lomecel-B Infusion in Aging Frailty Subjects to Improve Immune Response Following Influenza Vaccination
Published:
2021-04-15
(Crawled : 13:00)
- globenewswire.com
LGVN
|
News
P
6 d
|
$2.08
-41.08%
-69.71%
3.3M
|
|
-52.87%
|
O:
-2.0%
H:
3.54%
C:
-2.72%
influenza
response
vaccine
lomecel-b
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.